WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Stock Jumps 13.5% – What’s Next?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) shares rose 13.5% during mid-day trading on Thursday. The stock traded as high as $12.60 and last traded at $12.48. 1,737 shares were traded during mid-day trading, a decline of 98% from the average session volume of 70,057 shares. The stock had previously closed at $11.00.

Wall Street Analyst Weigh In

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, WuXi Biologics (Cayman) currently has an average rating of “Hold”.

WuXi Biologics (Cayman) Price Performance

The firm’s 50-day moving average price is $12.78 and its 200-day moving average price is $10.25.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide.

Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.

Based in China and operating internationally, WuXi Biologics supports customers across multiple regions through a network of research and manufacturing facilities.